Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:21:09.524Z.
Calculation as of: 2026-10-06T18:21:09.524Z.
Quote observation: 2026-10-06T17:39:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$263.18M
EV/EBIT Ratio
N/A
Market Cap
$261.39M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $263.18M | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | N/A |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.51M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.45M | N/A |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $261.27M | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.25M | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.85M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
